Guggenheim Maintains Buy on Erasca, Raises Price Target to $21

Benzinga Newsdesk www.benzinga.com Positive 54.7%

Neg 0% Neu 0% Pos 54.7%

Guggenheim analyst Paul Jeng maintains Erasca (NASDAQ:ERAS) with a Buy and raises the price target from $20 to $21.

Comments

No comments yet. Be the first!